Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership as they build world class marketing organizations for both the neurology and oncology business units. Current talent searches are underway for senior marketers with a track record of success with the HCP and patient/caregiver audiences.Ipsen Biopharmaceuticals, Inc., is headquartered in Basking Ridge, New Jersey. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases in three franchises: neurology, endocrinology and uro-oncology.
Ipsen Retains The Chase Group for Senior Marketers
Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership as they build world class marketing organizations for both the neurology and oncology business units. Current talent searches are underway for senior marketers with a track record of success with the HCP and patient/caregiver audiences.Ipsen Biopharmaceuticals, Inc., is headquartered in Basking Ridge, New Jersey. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases in three franchises: neurology, endocrinology and uro-oncology.- Categories: Biotechnology, Life Sciences, Pharmaceutical
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,…